Wednesday, December 20, 2017

Indian pharma's Chinese crisis: Firms fear profit hit on cost hikes

“Such a high dependency (on a single source) means that any disruption in the supply of APIs can potentially result in significant shortages of essential drugs in India,” said Ravind Mithe, partner, strategy & operations, KPMG. The high dependence has also been dubbed as a health security risk and
Delivered by KPMG Today (@KPMG_TO)
Article continues here
Follow @KPMG_TO on Twitter to get latest updates